Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: Role of adenosine acting on A 1 receptors

British Journal of Pharmacology

Volumn 158, Issue 2, 2009, Pages 558-568

  Valerio D A ^a   Ferreira, F I ^a   Cunha, T M ^a   Alves Filho, J C ^a   Lima, F O ^a   De Oliveira, J R ^b   Ferreira, S H ^a   Cunha, F Q ^a   Queiroz, R H ^a   Verri Jr , W A ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Adenosine; Cytokine; D Fructose 1,6 bisphosphate; DPCPX; Pain

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; CARRAGEENAN; CXCL1 CHEMOKINE; DOPAMINE; FRUCTOSE 1,6 BISPHOSPHATE; INTERLEUKIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL;

ADENOSINE; ANALGESICS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRUCTOSEDIPHOSPHATES; HYPERALGESIA; INFLAMMATION; MALE; MICE; PAIN MEASUREMENT; RECEPTOR, ADENOSINE A1;

EID: 69549126273     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00325.x     Document Type: Article

References (62)

1. Ahn SM, Yoon HY, Lee BG, Park KC, Chung JH, Moon CH et al. (2002). Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVB-irradiated HaCaT keratinocytes. Br J Pharmacol 137 : 497 503.
2. Akimitsu T, White JA, Carden DL, Gute DC, Korthuis RJ (1995). Fructose-1,6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle. Am J Physiol 269 : H1743 H1751.
3. Alves-Filho JCF, Vianna-Santos RC, Castaman TA, De Oliveira JR (2004). Anti-inflammatory effects of fructose-1,6-bisphosphate on carrageenan-induced pleurisy in rat. Pharmacol Res 49 : 245 248.
4. Bailey E, Stirpe F, Taylor CB (1968). Regulation of rat liver pyruvate kinase. The effect of preincubation, pH, copper ions, fructose 1,6-diphosphate and dietary changes on enzyme activity. Biochem J 108 : 427 436.
5. Bordignon Nunes F, Meier Graziottin C, Alves Filho JC, Lunardelli A, Caberlon E, Peres A et al. (2003). Immunomodulatory effect of fructose-1,6-bisphosphate on T-lymphocytes. Int Immunopharmacol 3 : 267 272.
6. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 : 206 209.
7. Casagrande R, Georgetti SR, Verri WA Jr., Dorta DJ, Dos Santos AC, Fonseca MJ (2006). Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B 84 : 21 27.
8. Cohly H, Jenkins J, Skelton T, Meydrech E, Markov AK (2004). Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, 6, beta-actin mRNAs, and transcription factors expression. Immunol Invest 33 : 407 421.
9. Cuesta E, Boada J, Calafell R, Perales JC, Roiq T, Bermudez J (2006). Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats. Crit Care Med 34 : 807 814.
10. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH (1991). Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104 : 765 767.
11. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992). The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107 : 660 664.
12. Cunha TM, Verri WA Jr., Vivancos GG, Moreira IF, Reis S, Parada CA et al. (2004). An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37 : 401 407.
13. Cunha TM, Verri WA Jr., Silva JS, Poole S, Cunha FQ, Ferreira SH (2005). A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102 : 1755 1760.
14. Cunha TM, Verri WA Jr., Poole S, Parada CA, Cunha FQ, Ferreira SH (2007). Pain facilitation by proinflammatory cytokine actions at peripheral nerve terminals. In : Sorkin L, DeLeo J, Watkins LR (eds). Immune and Glial Regulation of Pain. IASP Press : Seattle, WA. pp. 67 105.
15. Cunha TM, Verri WA Jr., Schivo IR, Napimoga MH, Parada CA, Poole S et al. (2008a). Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 83 : 824 832.
16. Cunha TM, Verri WA Jr., Valerio DA, Guerrero AT, Nogueira LG, Vieira SM et al. (2008b). Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice. Eur J Pain 12 : 1059 1068.
17. De Oliveira JR, Rosa JL, Ambrosio S (1992). Effect of galactosamine on hepatic carbohydrate metabolism; protective role of fructose-1,6-bisphosphate. Hepatology 15 : 1147 1153.
18. Ehringer WD, Niu W, Chiang B, Wang OL, Gordon L, Chien S (2000). Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells. Mol Cell Biochem 210 : 35 45.
19. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S (1988). Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 : 689 700.
20. 2. J Leukoc Biol 83 : 122 130.
21. Hardin CD, Roberts TM (1994). Metabolism of exogenously applied fructose-1,6-bisphosphate in hypoxic vascular smooth muscle. Am J Physiol 267 : H2325 H2332.
22. Hirokawa F, Nakai T, Yamaue H (2002). Storage solution containing fructose-1,6-bisphosphate inhibits the excess activation of Kupffer cells in cold liver preservation. Transplantation 74 : 779 783.
23. Irving MG, Williams JF (1973). Kinetic studies on the regulation of rabbit liver pyruvate kinase. Biochem J 131 : 287 301.
24. Jurna I (1984). Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord. Naunyn Schmiedebergs Arch Pharmacol 327 : 23 30.
25. Kirtley ME, McKay M (1977). Fructose-1,6-bisphosphate, a regulator of metabolism. Mol Cell Biochem 18 : 141 149.
26. Kuribara H, Higushi Y, Tadokoro S (1977). Effects of central depressants on rota-rod and traction performances in mice. Jpn J Pharmacol 27 : 117 126.
27. Lavich TR, Siqueira Rde A, Farias-Filho FA, Cordeiro RS, Rodrigues e Silva PM, Martins MA (2006). Neutrophil infiltration is implicated in the sustained thermal hyperalgesic response evoked by allergen provocation in actively sensitized rats. Pain 125 : 180 187.
28. Levine JD, Lau W, Kwiat G, Goetzl EJ (1984). Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 225 : 743 745.
29. Levine JD, Fields HL, Basbaum AI (1993). Peptides and the primary afferent nociceptor. J Neurosci 13 : 2273 2286.
30. Li J, Perl ER (1994). Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol 72 : 1611 1621.
31. Lopes RP, Lunardelli A, Preissler T, Leite CE, Alves-Filho JC, Nunes FB et al. (2006). The effects of fructose-1,6-bisphosphate and dexamethasone on acute inflammation and T-cell proliferation. Inflamm Res 55 : 354 358.
32. Markov AK, Rayburn TS, Talton DS, Netherland DE, Moore C, Heath B et al. (2002). Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression. Transplantation 74 : 1651 1654.
33. Mauborgne A, Polienor H, Hamon M, Cesselin F, Bourgoin S (2002). Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. Eur J Pharmacol 441 : 47 55.
34. Mihas AA, Kanji VK, Mihas TA, Joseph RM, Markov AK, Heuman DM (2003). Fructose diphosphate attenuates the acetaminophen-induced liver injury in the rat evidence for involvement of nitric oxide. Res Commun Mol Pathol Pharmacol 113 114 : 253 266.
35. Moresco RN, Santos RC, Alves-Filho JC, Cunha AA, Dos Reis C, Reichel CL et al. (2004). Protective effect of fructose-1,6-bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation. Transplant Proc 36 : 1261 1264.
36. Nuutinen EM, Lazzarino G, Giardina B, Hassinen IE (1991). Effect of exogenous fructose-1,6-bisphosphate on glycolysis in the isolated perfused rat heart. Am Heart J 122 : 523 527.
37. Planas ME, Sanchez S, Gonzalez P, De Oliveira JR, Bartrons R (1993). Protective effect of fructose-1,6-bisphosphate against carrageenan-induced inflammation. Eur J Pharmacol 237 : 251 255.
38. Rang HP, Bevan SJ, Dray A (1994). Nociceptive peripheral neurones: cellular properties. In : Wall PD, Melzack R (eds). Textbook of Pain. Churchill Livingstone : Edinburgh, pp. 57 78.
39. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH et al. (2000). Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387 : 111 118.
40. Santicioli P, Del Bianco E, Tramontana M, Maggi CA (1992). Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord. Neurosci Lett 144 : 211 214.
41. Santicioli P, Del Bianco E, Maggi CA (1993). Adenosine A1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur J Pharmacol 231 : 139 142.
42. Sawynok J (1998). Adenosine receptor activation and nociception. Eur J Pharmacol 347 : 1 11.
43. Sawynok J, Sweeney MI, White TD (1986). Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 88 : 923 930. (Pubitemid 16013101)
44. Sawynok J, Reid A, Poon A (1998). Peripheral antinociceptive effects of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor in the rat formalin test. Pain 74 : 75 81.
45. Schmidt AP, Böhmer AE, Antunes C, Schallenberger C, Porciúncula LO, Elisabetsky E et al. (2009). Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol 156 : 163 172.
46. Sola A, Panes J, Xaus C, Hotter G (2003). Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. J Leukoc Biol 73 : 74 81.
47. Taiwo YO, Levine JD (1990). Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 38 : 757 762.
48. Tamaki T, Nakai T, Yamaue H (2002). Fructose-1,6-Bisphosphate inhibits excess activation of Kupffer cell function induced by endotoxin. Dig Dis Sci 47 : 2179 2185.
49. Taylor CB, Bailey E (1967). Activation of liver pyruvate kinase by fructose 1,6-diphosphate. Biochem J 102 : 32 33.
50. Ting E, Guerrero AT, Cunha TM, Verri WA Jr., Taylor SM, Woodruff TM et al. (2008). Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain. Br J Pharmacol 153 : 1043 1053.
51. Vale ML, Benevides VM, Sachs D, Brito GA, da Rocha FA, Poole S et al. (2004). Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain. Br J Pharmacol 143 : 833 844.
52. Valerio DA, Cunha TM, Arakawa NS, Lemos HP, Da Costa FB, Parada CA et al. (2007). Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. Eur J Pharmacol 562 : 155 163.
53. Verri WA Jr., Schivo IR, Cunha TM, Liew FY, Ferreira SH, Cunha FQ (2004). Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner. J Pharmacol Exp Ther 310 : 710 717.
54. Verri WA Jr., Molina RO, Schivo IR, Cunha TM, Parada CA, Poole S et al. (2005). Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats. J Pharmacol Exp Ther 315 : 609 615.
55. Verri WA Jr., Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH (2006a). Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112 : 116 138.
56. Verri WA Jr., Cunha TM, Parada CA, Wei XQ, Ferreira SH, Liew FY et al. (2006b). IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci USA 103 : 9721 9725.
57. Verri WA Jr., Cunha TM, Poole S, Ferreira SH, Cunha FQ (2007a). Cytokine inhibitors and pain control. Rev Bras Reumatol 47 : 341 353.
58. Verri WA Jr., Cunha TM, Parada CA, Poole S, Liew FY, Ferreira SH et al. (2007b). Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun 21 : 535 543.
59. Verri WA Jr., Cunha TM, Ferreira SH, Wei X, Leung BP, Fraser A et al. (2007c). IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 37 : 3373 3380.
60. Verri WA Jr., Cunha TM, Magro DA, Domingues AC, Vieira SM, Souza GR et al. (2008a). Role of IL-18 in overt pain-like behaviour in mice. Eur J Pharmacol 588 : 207 212.
61. Verri WA Jr., Guerrero AT, Fukada SY, Valerio DA, Cunha TM, Xu D et al. (2008b). IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci USA 105 : 2723 2728.
62. Verri WA Jr., Cunha TM, Magro DA, Guerrero AT, Vieira SM, Carregaro V et al. (2009). Targeting endothelin ET(A) and ET(B) receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn Schmiedebergs Arch Pharmacol 379 : 271 279.